Top 3 Hockey Prospects for Card Collectors to Research Right Now: Gavin McKenna, Porter Martone, and Anton Frondell

Prospect collecting gets messy fast when hype, licensing, rookie rules, and product timing all get folded into the same conversation. A player can be highly ranked by NHL media, appear on an early checklist, and still carry real uncertainty about usage, release timing, or long-term hobby demand.

For collectors who want a tighter starting point as of September 27, 2026, the cleanest Top 3 is the current top three on NHL.com’s dated 2026-27 prospect ranking that is explicitly limited to Calder-eligible players: Gavin McKenna, Porter Martone, and Anton Frondell. That framework matters because it defines who still qualifies as a prospect for this purpose instead of relying on vague prospect hype.

What follows is not a prediction piece and not a promise of future value. It is a collector’s research guide built around current official ranking context, card-availability clues, licensing distinctions, and the specific risks that should shape what you buy, what you avoid, and what you verify before spending more heavily.

Start with the ranking framework, not social-media buzz

If you are going to build a Top 3 list for hockey prospect cards, the first step is choosing a framework that is dated, named, and limited by a clear eligibility rule. As of the research date, NHL.com’s 2026-27 prospect ranking offers exactly that. The list was published September 9, 2026, selected by Adam Kimelman, Mike G. Morreale, and Sebastien Deschambault, and restricted to players who still meet Calder rookie-eligibility rules.

That matters because prospect talk often drifts into a mix of junior stars, recent draftees, college standouts, and already-established NHL contributors. NHL.com’s eligibility standard narrows the pool to players with fewer than 26 NHL games in any prior season, not six or more games in each of two prior seasons, and under age 26 by Sept. 15 of the eligible season. For collectors, that creates a more practical shopping list than broad draft chatter because it aligns with players who are still crossing into mainstream NHL card attention.

Using that framework also keeps the Top 3 less subjective. Rather than inventing a personal ranking or chasing the loudest hobby narrative, you can work from the official order in that specific prospect list: McKenna at No. 1, Martone at No. 2, and Frondell at No. 3. That does not make them automatic hobby winners. It simply makes them the most defensible three names to research first under a stated, current methodology.

• Ask first: Is this player still Calder-eligible as of the ranking date?
• Use dated rankings, not recycled draft-season headlines, when prioritizing prospect research.
• Treat any Top 3 as time-stamped. This one is anchored to September 27, 2026, using NHL.com’s September 9, 2026 ranking.

Why licensing language matters before you buy a single card

Collectors regularly blur together league licensing, team marks, player group rights, and autograph agreements. In hockey, those are not the same thing. The NHL and NHLPA announced in October 2021 that Upper Deck’s licenses were extended as the exclusive licensed manufacturer of physical trading cards for NHL and NHLPA offerings. That is an important baseline for pack-issued NHL cards with league and player-group licensing attached.

But that league-and-union structure does not automatically mean the same company holds every prospect’s separate individual autograph or memorabilia arrangement. Upper Deck has also announced individual prospect deals, including an exclusive autograph trading-card agreement for Gavin McKenna and a separate trading-card and memorabilia deal for James Hagens. The practical lesson is simple: seeing a player in a licensed NHL product and seeing a player tied to an autograph-rights announcement are two different collector signals.

This distinction helps you avoid overclaiming what a product listing proves. An official checklist can confirm that a card exists in that set. A company press release can confirm a signed-card arrangement for a specific player. Neither one should be stretched into a blanket statement about every future product, every insert family, or every autograph format. The more precise your language, the fewer expensive assumptions you make.

• League and NHLPA card licensing is one rights bucket.
• Individual autograph agreements are another rights bucket.
• A checklist confirms card presence, not the full future roadmap for every rookie release.

1) Gavin McKenna: the clearest No. 1 name, with the clearest hype risk

As of September 9, 2026, NHL.com ranked Gavin McKenna as the No. 1 prospect for the 2026-27 season, and that alone makes him the first file every hockey-card collector should open. The same ranking notes that he was the No. 1 pick in the 2026 NHL Draft and remains within the Calder-eligible prospect pool. For a collector, that combination is unusually clean: top official ranking, top draft status, and current eligibility under the same published framework.

There is also stronger card-rights clarity here than with many prospects. Upper Deck announced on June 26, 2026 that it holds McKenna’s exclusive NHL autographed trading-card rights. The company specifically said his rookie cards are planned in 2026-27 products including Young Guns and Future Watch. That does not lock in exact release dates or precise checklist sequencing, but it does give collectors two meaningful anchors: the player is expected in major rookie-brand lanes, and Upper Deck publicly tied itself to his autograph-card rights.

McKenna’s appeal is easy to understand, but so is the biggest trap. Much of the enthusiasm depends on projected role and projected impact, not an already-completed NHL body of work. NHL.com’s writeup points to top-six upside, and that kind of projection can create pre-release pricing heat before collectors know how his first NHL usage will actually look. If you are buying early, the disciplined move is to separate confirmed facts from future storyline. The facts are the ranking, draft status, eligibility, and autograph-rights announcement. Everything else needs proof over time.

• Research target: confirmed 2026-27 rookie appearances in flagship-style brands once full checklists post.
• Buying question: Do you want early access, or do you want to wait until role and product timing are more visible?
• Risk to monitor: a premium price driven by projection before a long NHL sample exists.

How to research McKenna without overpaying for the story

If you are building a McKenna plan, start by deciding whether you collect rank, release, or autograph. A rank-driven collector may want an early licensed card tied to his immediate prospect moment. A release-driven collector may prefer to wait for mainstream rookie-brand entries that are easier to identify and compare across years. An autograph-driven collector will care more about which signed formats actually surface and how they are distributed than about being first to own anything with his name on it.

A practical approach is to make a three-column checklist for him. Column one is verified card presence: which 2026-27 products officially list him once checklists appear. Column two is rights clarity: where Upper Deck has explicitly confirmed planned rookie-card placement or autograph rights. Column three is role confirmation: how quickly he reaches a stable NHL spot relative to the excitement baked into early asking prices. That structure turns hype into a repeatable buying process.

The tradeoff is timing. Waiting can mean missing the first wave of collector enthusiasm if he debuts hot. Buying too early can mean paying for assumptions if release schedules shift or on-ice deployment starts slower than expected. There is no universally correct answer. The key is knowing which uncertainty you are accepting: product uncertainty, performance uncertainty, or pricing uncertainty.

• Example approach: buy one modest early licensed card now, then wait on bigger purchases until flagship rookie details are fully confirmed.
• If you prefer autographs, verify whether the signed card is pack-issued, a redemption, or from another release format before comparing prices.
• Treat Young Guns and Future Watch mentions as strong signals, not as a substitute for final checklist confirmation.

2) Porter Martone: already on a rookie checklist, but still a development bet

Porter Martone slots second on the same September 9, 2026 NHL.com prospect ranking, which gives him a strong official case before you even get to cards. NHL.com also notes that he played nine NHL regular-season games after his freshman season at Michigan State, which keeps him inside the Calder-eligibility limits described in that ranking framework. For collectors, that is useful because it means you are not guessing whether he still qualifies as a prospect under this list’s rules.

His card trail is already more tangible in one area than some collectors may expect. Upper Deck’s 2026-27 Artifacts Checklist lists Porter Martone as a Rookie. That is not the same thing as confirming every major rookie card format you may care about, but it does provide an official, licit product anchor. If you want proof that Martone already exists in a current NHL-licensed release as a rookie, the checklist gives you that.

The caution with Martone is not that he lacks upside. It is that NHL.com specifically ties part of his long-term ceiling to continued skating improvement. For collectors, that becomes a helpful filter. Instead of buying on name value alone, you can monitor whether his early NHL usage and team confidence support the idea of steady development. His late-season NHL sample may encourage buyers, but nine games is still too little to treat as settled evidence of what his full-season value proposition will be.

• Collector fact: he is already listed as a Rookie on the 2026-27 Artifacts Checklist.
• On-ice risk factor to track: skating development, specifically noted in NHL.com’s writeup.
• Process tip: do not let a small NHL sample harden into a certainty in your pricing model.

What to check before buying Martone cards

Martone is a good example of why official checklist evidence should change how you shop. If a player is already confirmed in a licensed set, you no longer have to speculate about whether cards exist. Your questions become more practical: Which version of the rookie card matters to you, how easy is it to identify, and are you paying a premium just because the product was first to market?

One sensible strategy is to compare early-set rookie cards by function, not just by brand prestige. For example, a collector building a broad rookie portfolio might prefer a lower-cost, clearly designated early rookie from Artifacts as a placeholder while waiting to see how flagship-style options shake out. Another collector may skip that entirely and concentrate only on the rookie format they personally consider central to their hockey collection. That preference is subjective, and it should stay subjective rather than being dressed up as a universal hierarchy.

There is also a condition and identification angle. Before buying, confirm the exact card numbering, parallel status, and whether the listing is for a base rookie, a serial-numbered variation, or an autograph version. Prospect excitement creates plenty of vague listings. The more a player’s market leans on developing hype, the more important exact set identification becomes.

• Good buyer questions: Is this the base rookie, a parallel, a patch card, or an autograph?
• Does the price reflect true scarcity, or simply the fact that the card appeared early?
• Would you still want this card if a more widely chased rookie format arrives a few months later?

3) Anton Frondell: official top-three ranking, official rookie checklist, and role uncertainty worth respecting

Anton Frondell rounds out the current top three by sitting No. 3 on NHL.com’s 2026-27 prospect ranking. According to that article, he played 12 NHL games last season after finishing with Djurgarden in the Swedish Hockey League, which keeps him inside the same Calder-based eligibility framework used for the list. In other words, his inclusion is not a loose media opinion detached from rookie rules; it fits the published criteria applied to the entire ranking.

From a collector standpoint, Frondell has one of the more useful early signals available: Upper Deck’s 2026-27 Artifacts Checklist lists him as a Rookie. Like Martone, that checklist confirmation does not answer every rookie-card question, but it does remove one major uncertainty. There is already an official licensed release where you can verify his presence rather than waiting on rumor or secondhand social posts.

The bigger question is deployment and context. NHL.com’s optimism around Frondell includes a limited NHL sample and notes immediate usage context affected by Connor Bedard’s recovery from shoulder surgery. For collectors, that should be read as a context note, not a permanent role guarantee. If a player’s early opportunity is partly shaped by temporary roster conditions, then card demand can swing hard if lines, ice time, or expectations shift once the roster normalizes. That does not make Frondell a fade. It simply means his hobby case needs regular role tracking, not just ranking-based confidence.

• Verified now: top-three official prospect rank and rookie presence on the 2026-27 Artifacts Checklist.
• Main uncertainty: how stable his NHL role looks over a longer run than 12 games.
• Collector discipline: separate early opportunity from locked-in long-term usage.

How to compare these three without pretending they are equal buys

It is tempting to treat a Top 3 list like a shopping order. That is not always useful. McKenna, Martone, and Frondell share the same broad prospect framework, but their collector setups are different. McKenna brings the strongest official ranking plus a separate Upper Deck announcement about exclusive NHL autographed trading-card rights and planned rookie appearances in marquee product families. Martone and Frondell, by contrast, have immediate official rookie checklist confirmation in 2026-27 Artifacts, which gives you a concrete set anchor today.

That means the smartest buy is partly about your collecting style. If you care most about highest-ranked upside and named autograph-rights clarity, McKenna is the obvious research priority. If you want a player with current official rookie checklist visibility in a released product structure, Martone and Frondell may be easier to approach methodically. Neither path is inherently superior. They solve different collector goals.

The tradeoff is that clarity in one lane does not erase uncertainty in another. McKenna’s roadmap is stronger on autograph-rights language, but exact product sequencing still matters. Martone and Frondell have clear checklist proof in Artifacts, but each still carries on-ice development and role questions. This is why ranking alone should not dictate spending level. Ranking tells you where to look first. Product evidence and player context should decide how aggressively you buy.

• McKenna: strongest combination of No. 1 ranking and named autograph-rights announcement.
• Martone: No. 2 ranking plus rookie checklist confirmation in Artifacts.
• Frondell: No. 3 ranking plus rookie checklist confirmation in Artifacts.

A practical monthly research routine for prospect collectors

Prospect collecting is easier when you turn it into a recurring checklist instead of a mood. Once you have your three names, review the same categories each month. First, verify whether new official checklists have added rookie cards, inserts, or autographs for those players. Second, note any public product pages or brand pages that clarify release sequencing. Third, compare that card-release progress with how each player is actually being discussed in current official coverage tied to role and development.

A simple worksheet can keep you from reacting to every listing. For each player, track official ranking date, last confirmed licensed product appearance, whether autograph rights have been publicly addressed, and the biggest on-ice uncertainty named in official writeups. Then, when a card surfaces, ask whether the price reflects something newly confirmed or merely recycled excitement. That difference is where many prospect overpays happen.

This routine also helps you stay honest about what you know. If your notes show that a player’s most important hobby talking point is still a projection, then your buying size should probably stay modest. If your notes show multiple confirmed products and a more stable NHL role, you may decide to upgrade. The point is not to eliminate risk. The point is to choose it deliberately.

• Monthly check 1: new official checklists.
• Monthly check 2: product-page updates and release sequencing.
• Monthly check 3: official role and development notes in NHL coverage.
• Monthly check 4: whether asking prices are reacting to facts or to narrative momentum.

The bottom line: why these are the right three to research first as of September 27, 2026

If your goal is to identify exactly three hockey prospects to research right now using current eligibility, an official ranking, and a stated methodology, the answer is straightforward as of September 27, 2026: Gavin McKenna, Porter Martone, and Anton Frondell. They are the top three names on NHL.com’s September 9, 2026 prospect ranking, and that ranking is explicitly filtered for Calder-eligible players.

For collectors, each offers a different kind of useful evidence. McKenna gives you the strongest blend of top ranking, top draft status, and named exclusive NHL autographed trading-card rights announced by Upper Deck. Martone gives you a No. 2 official ranking plus current rookie checklist confirmation in 2026-27 Artifacts. Frondell gives you the No. 3 official ranking plus the same kind of rookie checklist proof, along with a role context that rewards careful monitoring.

That does not mean you must buy all three, or buy them immediately, or treat them as equal hobby bets. It means these are the three files most worth opening first if you want a collector process built on current official evidence instead of noise. Research the ranking date. Verify the checklist. Separate licensing layers. Respect the risks. Then buy only the uncertainty you actually understand.

• Best first name to study for autograph-rights clarity: Gavin McKenna.
• Best current product anchor for Martone and Frondell: 2026-27 Artifacts rookie checklist inclusion.
• Most important collector habit: treat all prospect lists as dated snapshots, not permanent truths.

Illustration generated for this guide; not a photograph of an actual card, product or event.